Discover 194 paid clinical trials in Vermont. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Vermont offers a variety of opportunities for both healthy volunteers interested in taking part in paid studies and those with specific health conditions. Research centers in Burlington, Rutland, and Montpelier are actively recruiting, granting access to cutting-edge therapies and innovative medical care.
Filter
1
Filter results
Results: 194
Active & Responsive
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Springfield MA, Saint Johnsbury VT, Lebanon NH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05136196
Phase 2, Recruiting
Active & Responsive
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Saint Johnsbury VT, Lebanon NH, Commack NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06589804
Phase 3, Recruiting
Active & Responsive
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
for
Generalized Myasthenia Gravis
Location: Boston MA, New Haven CT, New Hyde Park NY,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT04202341
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
American Lung Association (ALA) Lung Health Cohort
for
Lung Diseases
Location: Hawthorne NY, New York NY, Colchester VT,
Sponsor: Johns Hopkins University
Sex: All
Age: 25 - 35
Code: NCT04543461
Recruiting
Active & Responsive
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
for
Major Depressive Disorder
Location: Boston MA, Worcester MA, Bennington VT, Philadelphia PA,
Sponsor: Definium Therapeutics US, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07592689
Phase 3, Recruiting
Active & Responsive
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
for
COPD
Location: Boston MA, Burlington MA, Burlington VT, Montreal,
Sponsor: Temple University
Sex: All
Age: 30+
Code: NCT05204888
Recruiting
Active & Responsive
Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes
for
Tobacco Use Disorder
Location: Providence RI, Burlington VT
Sponsor: University of Vermont
Sex: All
Age: 21+
Code: NCT06614504
Phase 2, Recruiting
Active & Responsive
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
for
Primary Central Nervous System Lymphoma
Location: New York NY, Burlington VT, Hershey PA,
Sponsor: Providence Health & Services
Sex: All
Age: 18+
Code: NCT06175000
Phase 2, Recruiting
Active & Responsive
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
for
Generalized Myasthenia Gravis
Location: Farmington CT, Burlington VT, Washington D.C. DC,
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Sex: All
Age: 18+
Code: NCT06463587
Phase 3, Recruiting
Active & Responsive
IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)